Abstract:BACKGROUND: Catheter ablation as first-line therapy for ventricular tachycardia (VT) at the time of implantable cardioverter defibrillator (ICD) implantation has not been adopted into clinical guidelines. Also, there is an unmet clinical need to prospectively examine the role of VT ablation in patients with nonischemic cardiomyopathy, an increasingly prevalent population that is referred for advanced therapies globally. METHODS: We conducted an international, multicenter, randomized controlled trial enrolling 180 patients with cardiomyopathy and monomorphic VT with an indication for ICD implantation to assess the role of early, first-line ablation therapy. A total of 121 patients were randomly assigned (1:1) to ablation plus an ICD versus conventional medical therapy plus an ICD. Patients who refused ICD (n=47) were followed in a prospective registry after stand-alone ablation treatment. The primary outcome was a composite end point of VT recurrence, cardiovascular hospitalization, or death. RESULTS: Randomly assigned patients had a mean age of 55 years (interquartile range, 46-64) and left ventricular ejection fraction of 40% (interquartile range, 30%-49%); 81% were male. The underlying heart disease was ischemic cardiomyopathy in 35%, nonischemic cardiomyopathy in 30%, and arrhythmogenic cardiomyopathy in 35%. Ablation was performed a median of 2 days before ICD implantation (interquartile range, 5 days before to 14 days after). At 31 months, the primary outcome occurred in 49.3% of the ablation group and 65.5% in the control group (hazard ratio, 0.58 [95% CI, 0.35-0.96]; P=0.04). The observed difference was driven by a reduction in VT recurrence in the ablation arm (hazard ratio, 0.51 [95%CI, 0.29-0.90]; P=0.02). A statistically significant reduction in both ICD shocks (10.0% versus 24.6%; P=0.03) and antitachycardia pacing (16.2% versus 32.8%; P=0.04) was observed in patients who underwent ablation compared with control. No differences in cardiovascular hospitalization (32.0% versus. 33.7%; hazard ratio, 0.82 [95% CI, 0.43-1.56]; P=0.55) or mortality (8.9% versus 8.8%; hazard ratio, 1.40 [95% CI, 0.38-5.22]; P=0.62]) were observed. Ablation-related complications occurred in 8.3% of patients. CONCLUSIONS: Among patients with cardiomyopathy of varied causes, early catheter ablation performed at the time of ICD implantation significantly reduced the composite primary outcome of VT recurrence, cardiovascular hospitalization, or death. These findings were driven by a reduction in ICD therapies.

GW25-e1541 Frequent Premature Ventricular Complexes Ablation Improves Left Ventricular Function

GW26-e4813 Impact of Anatomically-guided Ganglionated Plexus Ablation on Electrical Firing from Isolated Pulmonary Veins

GW29-e1031 Catheter Ablation of PVCs Originating from Papillary Muscles Guided by Transthoracic Echocardiography

Symptomatic Premature Ventricular Contractions in Vasovagal Syncope Patients: Autonomic Modulation and Catheter Ablation

Electrocardiogram Characteristics and Radiofrequency Catheter Ablation of Premature Ventricular Contraction Arrhythmias under the Left Coronary Cusp

Electrophysiological Characteristics and Ablation Outcomes in Patients With Catecholaminergic Polymorphic Ventricular Tachycardia

Chronic aspiration of gastric and duodenal contents and their effects on inflammatory cytokine production in respiratory system of rats.

Left Atrial Function Is Improved in Short-Term Follow-Up after Catheter Ablation of Outflow Tract Premature Ventricular Complexes

Catheter ablation of premature ventricular complexes associated with left ventricular false tendons

Efficacy and safety of circumferential pulmonary vein ablation combined complex fractionated atrial electrograms ablation for atrial fibrillation

Premature ventricular complexes after catheter ablation for atrial fibrillation: Accounting for regression to the mean

Real World Data from Catheter Ablation of Ventricular Tachycardias and Premature Ventricular Complexes in a Tertiary Care Center

Premature ventricular contractions with acute successful radiofrequency catheter ablation near the atrioventricular node using reversed C curve technique

Myocardial work in idiopathic premature ventricular contractions: Assessing left ventricular function and prognosis

Electrophysiological characteristics and radiofrequency catheter ablation of paroxysmal supraventricular tachycardia associated with persistent left superior vena cava

GW28-e0603 the Characteristics of Patients with Idiopathic Ventricular Fibrillation and Evaluation of the Efficacy with Radiofrequency Ablation Versus ICD: a Meta-Analysis of Individual Participant Data

Outcomes of single-procedure radiofrequency catheter ablation for idiopathic ventricular arrhythmias: a single-centre retrospective cohort study

First-Line Catheter Ablation of Monomorphic Ventricular Tachycardia in Cardiomyopathy Concurrent With Defibrillator Implantation: The PAUSE-SCD Randomized Trial

Catheter Ablation for Ventricular Tachycardia in Patients with Arrhythmogenic Right Ventricular Dysplasia/cardiomyopathy: a Systematic Review and Meta-Analysis.

Radiofrequency catheter ablation of premature ventricular contractions in pediatric patients without structural heart diseases

Circumferential myocardial contraction patterns in patients with idiopathic frequent premature ventricular complexes from the right ventricular outflow tract.